HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linlin Yin Selected Research

Neuromyelitis Optica (Devic's Disease)

1/2022NMO-IgG Induce Interleukin-6 Release via Activation of the NF-κB Signaling Pathway in Astrocytes.
10/2021Efficacy of mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
7/2021Elevated chemokines and cytokines for eosinophils in neuromyelitis optica spectrum disorders.
5/2021Efficacy of rituximab in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
10/2020Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK/STAT3 signaling pathway.
1/2019Low Serum Interleukin-10 Is an Independent Predictive Factor for the Risk of Second Event in Clinically Isolated Syndromes.
1/2018Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
1/2018CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linlin Yin Research Topics

Disease

10Multiple Sclerosis
10/2020 - 09/2012
8Neuromyelitis Optica (Devic's Disease)
01/2022 - 01/2018
4Neoplasms (Cancer)
01/2022 - 01/2017
4Demyelinating Diseases (Demyelinating Disease)
10/2021 - 09/2016
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2020 - 09/2014
3Inflammation (Inflammations)
09/2021 - 05/2020
2Hypoxia (Hypoxemia)
11/2022 - 11/2017
2Neurosyphilis (General Paresis of the Insane)
01/2020 - 01/2020
2Neuroblastoma
10/2012 - 08/2012
1Brain Injuries (Brain Injury)
11/2022
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022
1Infections
09/2021
1Pleural Effusion (Pleural Effusions)
09/2021
1Pneumonia (Pneumonitis)
09/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2021
1Healthcare-Associated Pneumonia
01/2021
1Bacterial Pneumonia
12/2020
1Body Weight (Weight, Body)
10/2020
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
07/2020
1Persistent Infection
01/2020
1Hyperlipidemias (Hyperlipidemia)
01/2020
1Liver Neoplasms (Liver Cancer)
01/2020
1Gestational Diabetes (Gestational Diabetes Mellitus)
01/2020
1Necrotizing Enterocolitis
01/2020
1Herpes Simplex Encephalitis (Herpes Encephalitis)
06/2019
1Colitis
06/2019
1Necrosis
06/2019
1Neuroinflammatory Diseases
01/2019
1Diabetes Mellitus
01/2018
1Osteoporosis
01/2018
1Metabolic Bone Diseases (Osteopenia)
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
11/2017
1Mouth Neoplasms (Oral Cancer)
07/2016
1Breast Neoplasms (Breast Cancer)
06/2016
1Medulloblastoma
02/2016
1Hypoglycemia (Reactive Hypoglycemia)
06/2015
1Hyperglycemia
06/2015
1Cognitive Dysfunction
01/2015

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
10/2021 - 09/2012
5Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2012
4CuprizoneIBA
10/2021 - 03/2015
4CytokinesIBA
07/2021 - 01/2018
4Pharmaceutical PreparationsIBA
01/2020 - 07/2016
3Immunoglobulin G (IgG)IBA
01/2022 - 01/2018
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2018
3icariinIBA
10/2021 - 01/2017
2Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2021 - 09/2016
2ProcalcitoninIBA
01/2021 - 12/2020
2Peptides (Polypeptides)IBA
10/2020 - 01/2019
2Myelin-Oligodendrocyte GlycoproteinIBA
07/2020 - 01/2018
2InterleukinsIBA
06/2019 - 10/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 01/2017
2IridoidsIBA
09/2016 - 09/2014
2GlycosidesIBA
09/2016 - 09/2014
1Competitive Endogenous RNAIBA
11/2022
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
10/2021
1Myelin Basic ProteinIBA
10/2021
1Luxol Fast Blue MBS (Luxol fast blue)IBA
10/2021
1EstersIBA
10/2021
1FlavonoidsIBA
10/2021
1oil red OIBA
10/2021
1Interleukin-17 (Interleukin 17)IBA
09/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021
1Messenger RNA (mRNA)IBA
09/2021
1ChemokinesIBA
07/2021
1Rituximab (Mabthera)FDA Link
05/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2020
1Aquaporins (Water Channels)IBA
10/2020
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
10/2020
1GlucocorticoidsIBA
10/2020
1Immunoglobulins (Immunoglobulin)IBA
10/2020
1CD40 Ligand (CD40L)IBA
05/2020
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1veratramineIBA
01/2020
1Interleukin-10 (Interleukin 10)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1apelin-13 peptideIBA
01/2018
1Aquaporin 4IBA
01/2018
1Bevacizumab (Avastin)FDA Link
11/2017
1ErythropoietinFDA Link
11/2017
1Capecitabine (Xeloda)FDA Link
01/2017
1CopperIBA
01/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1Chelating AgentsIBA
01/2017
1Nerve Growth Factors (Neurotrophins)IBA
09/2016
1Nerve Growth Factor (NGF)IBA
09/2016
1PolymersIBA
07/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2016
1Scavenger Receptors (Scavenger Receptor)IBA
06/2016
1ChromatinIBA
02/2016
1Insulin ReceptorIBA
06/2015
1Estrogens (Estrogen)FDA Link
01/2015
1LeptinIBA
01/2015
1ProteomeIBA
09/2012

Therapy/Procedure

7Therapeutics
11/2022 - 07/2016
3Drug Therapy (Chemotherapy)
01/2020 - 07/2016
1Immunotherapy
01/2018